| Intra-Cellular's (ITCI) Caplyta Boosts Sales, Dependence a Woe | 06/24 10:55 | zacks.com |
| Intra-Cellular (ITCI) Up as Second Depression Study Meets Goals | 06/19 11:30 | zacks.com |
| Intra-Cellular (ITCI) Soars 9.6%: Is Further Upside Left in the Stock? | 06/19 07:30 | zacks.com |
| Intra-Cellular Brightens MDD Outlook With Caplyta Success | 06/19 02:08 | seekingalpha.com |
| Intra-Cellular Therapies' Highlights Successful Data From Second Depression Study | 06/18 10:37 | benzinga.com |
| Intra-Cellular Therapies Announces Positive Topline Results in Second Phase 3 Trial Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder | 06/18 07:30 | globenewswire.com |
| Intra-Cellular Therapies to Present at the 45th Annual Goldman Sachs Global Healthcare Conference | 06/10 08:00 | globenewswire.com |
| Why Is Intra-Cellular (ITCI) Up 1.2% Since Last Earnings Report? | 06/06 12:35 | zacks.com |
| The Secret Stock Stash: 3 Overlooked Picks That Belong in Every Portfolio | 05/30 06:00 | investorplace.com |
| Intra-Cellular Therapies to Present at the Jefferies Global Healthcare Conference | 05/29 08:00 | globenewswire.com |